NASDAQ:OFIX - Orthofix Medical Stock Price, Forecast & News

Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OFIX shares have decreased by 13.1% and is now trading at $26.66. View which stocks have been mosted impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthofix Medical.

Orthofix Medical is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Orthofix Medical.

Orthofix Medical Inc (NASDAQ:OFIX) posted its earnings results on Monday, February, 24th. The medical device company reported $0.51 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.51. The medical device company had revenue of $121.49 million for the quarter, compared to analysts' expectations of $122.90 million. Orthofix Medical had a positive return on equity of 8.58% and a negative net margin of 6.19%. View Orthofix Medical's earnings history.

Orthofix Medical updated its first quarter 2020 After-Hours earnings guidance on Monday, February, 24th. The company provided earnings per share (EPS) guidance of 0.09-0.12 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.32. The company issued revenue guidance of $106-109 million, compared to the consensus revenue estimate of $113.27 million.

2 brokerages have issued twelve-month price targets for Orthofix Medical's stock. Their forecasts range from $42.00 to $56.00. On average, they expect Orthofix Medical's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 83.8% from the stock's current price. View analysts' price targets for Orthofix Medical.

News articles about OFIX stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Orthofix Medical earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutOrthofix Medical.

Orthofix Medical saw a drop in short interest in the month of March. As of March 13th, there was short interest totaling 224,700 shares, a drop of 40.4% from the February 27th total of 377,300 shares. Based on an average daily trading volume, of 174,700 shares, the days-to-cover ratio is presently 1.3 days. Currently, 1.2% of the shares of the company are sold short. View Orthofix Medical's Current Options Chain.

Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Insulet (PODD) and Masimo (MASI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Exxon Mobil (XOM), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL), Zogenix (ZGNX) and Allergan (AGN).

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of OFIX stock can currently be purchased for approximately $26.66.

Orthofix Medical has a market capitalization of $511.31 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 1,055 workers across the globe. View additional information about Orthofix Medical.

The official website for Orthofix Medical is http://www.orthofix.com/.

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]